Development of novel medications for use in the treatment of obesity in children will be directed by delineating controls of energy homeostasis.
Sherman
Philip M
PM
Zlotkin
Stanley H
SH
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D002648:Child; D015195:Drug Design; D004734:Energy Metabolism; D006801:Humans; D009765:Obesity / Q000188:drug therapy*
D019440:Anti-Obesity Agents